JP2019530729A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019530729A5 JP2019530729A5 JP2019520647A JP2019520647A JP2019530729A5 JP 2019530729 A5 JP2019530729 A5 JP 2019530729A5 JP 2019520647 A JP2019520647 A JP 2019520647A JP 2019520647 A JP2019520647 A JP 2019520647A JP 2019530729 A5 JP2019530729 A5 JP 2019530729A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- liposome
- phospholipid
- composition
- topical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 22
- 239000002502 liposome Substances 0.000 claims 10
- 150000003904 phospholipids Chemical class 0.000 claims 6
- 230000000699 topical effect Effects 0.000 claims 5
- RZZPDXZPRHQOCG-OJAKKHQRSA-M CDP-choline(1-) Chemical compound O[C@@H]1[C@H](O)[C@@H](COP([O-])(=O)OP([O-])(=O)OCC[N+](C)(C)C)O[C@H]1N1C(=O)N=C(N)C=C1 RZZPDXZPRHQOCG-OJAKKHQRSA-M 0.000 claims 4
- 229960000686 benzalkonium chloride Drugs 0.000 claims 4
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 claims 4
- 229960001284 citicoline Drugs 0.000 claims 4
- 239000002674 ointment Substances 0.000 claims 4
- 208000010412 Glaucoma Diseases 0.000 claims 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 2
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 229940030600 antihypertensive agent Drugs 0.000 claims 2
- 239000002220 antihypertensive agent Substances 0.000 claims 2
- 239000006071 cream Substances 0.000 claims 2
- 239000003889 eye drop Substances 0.000 claims 2
- 239000006260 foam Substances 0.000 claims 2
- 229920002674 hyaluronan Polymers 0.000 claims 2
- 229960003160 hyaluronic acid Drugs 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000000243 solution Substances 0.000 claims 2
- 239000007921 spray Substances 0.000 claims 2
- 239000000725 suspension Substances 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102016000103956A IT201600103956A1 (it) | 2016-10-17 | 2016-10-17 | Formulazione oftalmica comprendente citicolina veicolata da liposomi per il trattamento del glaucoma |
| IT102016000103956 | 2016-10-17 | ||
| PCT/IB2017/056400 WO2018073720A1 (en) | 2016-10-17 | 2017-10-16 | Ophthalmic formulation comprising citicoline carried by liposome for the treatment of glaucoma |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019530729A JP2019530729A (ja) | 2019-10-24 |
| JP2019530729A5 true JP2019530729A5 (enExample) | 2020-11-05 |
| JP7042262B2 JP7042262B2 (ja) | 2022-03-25 |
Family
ID=58010202
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019520647A Active JP7042262B2 (ja) | 2016-10-17 | 2017-10-16 | 緑内障の治療のための、リポソームによって担持されるシチコリンを含む眼科用処方 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10576039B2 (enExample) |
| EP (1) | EP3525758B1 (enExample) |
| JP (1) | JP7042262B2 (enExample) |
| EA (1) | EA201990752A1 (enExample) |
| ES (1) | ES2987910T3 (enExample) |
| IT (1) | IT201600103956A1 (enExample) |
| MX (1) | MX388927B (enExample) |
| TN (1) | TN2019000112A1 (enExample) |
| WO (1) | WO2018073720A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3412276B1 (de) | 2017-06-09 | 2025-11-19 | Omnivision GmbH | Zusammensetzung zur behandlung des trockenen auges |
| IT201800005309A1 (it) * | 2018-05-11 | 2019-11-11 | Composizione ad attivita’ antimicrobica | |
| CN110559261A (zh) * | 2018-06-06 | 2019-12-13 | 常州药物研究所有限公司 | 含有纳米交联透明质酸的脂质体微乳及其制备方法和应用 |
| CN111840220B (zh) * | 2020-08-19 | 2022-09-30 | 开封康诺药业有限公司 | 一种胞磷胆碱钠注射液及其制备方法 |
| MX2023013266A (es) * | 2021-05-10 | 2023-12-15 | Omikron Italia S R L | Solucion oral basada en citicolina y nicotinamida para usar en el tratamiento del glaucoma. |
| WO2025037323A1 (en) * | 2023-08-12 | 2025-02-20 | Pavan Kumar Kothapuvari | Pharmaceutical compositions for treatment of dry eye disease and associated disorders |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0114577A1 (en) * | 1983-01-21 | 1984-08-01 | MAGIS FARMACEUTICI S.p.A. | New pharmaceutical composition |
| AU2001292287A1 (en) * | 2000-10-26 | 2002-05-06 | Senju Pharmaceutical Co. Ltd. | Drug composition comprising dipeptydyl aldehyde derivative |
| JP2012517421A (ja) | 2009-02-11 | 2012-08-02 | ライカ ラブズ リミテッド | リポソームシチコリン注射薬 |
| IT1398378B1 (it) * | 2010-02-22 | 2013-02-22 | Omikron Italia S R L | Citicolina per il trattamento del glaucoma e dell'ipertensione oculare. |
| FR2961694B1 (fr) | 2010-06-29 | 2013-01-25 | Thea Lab | Systeme de delivrance polymerique d'une solution non visqueuse a base de prostaglandine sans conservateur |
| SG187770A1 (en) | 2010-08-12 | 2013-03-28 | Univ Nanyang Tech | A liposomal formulation for ocular drug delivery |
| CN102078299B (zh) * | 2011-01-04 | 2012-09-26 | 海南美大制药有限公司 | 胞磷胆碱钠脂质体固体制剂 |
-
2016
- 2016-10-17 IT IT102016000103956A patent/IT201600103956A1/it unknown
-
2017
- 2017-10-16 ES ES17811373T patent/ES2987910T3/es active Active
- 2017-10-16 EP EP17811373.4A patent/EP3525758B1/en active Active
- 2017-10-16 MX MX2019004463A patent/MX388927B/es unknown
- 2017-10-16 US US16/342,261 patent/US10576039B2/en active Active
- 2017-10-16 JP JP2019520647A patent/JP7042262B2/ja active Active
- 2017-10-16 WO PCT/IB2017/056400 patent/WO2018073720A1/en not_active Ceased
- 2017-10-16 EA EA201990752A patent/EA201990752A1/ru unknown
- 2017-10-16 TN TNP/2019/000112A patent/TN2019000112A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019530729A5 (enExample) | ||
| ES2461617T3 (es) | Composiciones farmacéuticas acuosas que contienen complejos borato-polioles | |
| JP2013535472A5 (enExample) | ||
| JP2023017050A5 (enExample) | ||
| EP2046287B1 (en) | Methods and compositions for the treatment and prevention of infections | |
| ES2708451T3 (es) | Soluciones de bimatoprost y timolol sin conservantes | |
| ATE428401T1 (de) | Suspensionsformulierungen mit einem aktiven wirkstoff, einem poloxamer- oder meroxapol-tensid und einem glycol und ihre verwendung zur herstellung eines medikaments zur behandlung von augenkrankheiten | |
| JP2019532105A5 (enExample) | ||
| JP2014515383A5 (enExample) | ||
| JP2002539153A5 (enExample) | ||
| JP2021107464A (ja) | 眼科組成物 | |
| JP2003146891A (ja) | 洗浄剤 | |
| CN102858352B (zh) | 含有鏻抗微生物剂的药物组合物 | |
| US20090258946A1 (en) | Electrostatically charged nasal application multipurpose products and method | |
| JP6253756B2 (ja) | 眼科用水性組成物 | |
| RU2442583C2 (ru) | Стабилизированные и консервированные глазные композиции, содержащие кетотифен | |
| ES2700775T3 (es) | Composiciones oftálmicas acuosas que contienen agentes terapéuticos aniónicos | |
| JP4239036B2 (ja) | 改良薬剤組成物 | |
| ES2974884T3 (es) | Composición de colirio para reducir la presión intraocular | |
| IL273213B2 (en) | Topical formulations of chloroprocaine | |
| JP2023001184A5 (enExample) | ||
| JPWO2021021646A5 (enExample) | ||
| JP2020533321A5 (enExample) | ||
| CN117323240A (zh) | 一种纳米脂质体包裹的阳离子抗菌洗手液 | |
| WO2022162254A1 (es) | Composición para su uso en forma de gotas nasales y nebulizadores como antiviral |